您的浏览器禁用了JavaScript(一种计算机语言,用以实现您与网页的交互),请解除该禁用,或者联系我们。[港股财报]:微泰医疗-B二零二五年中期报告 - 发现报告

微泰医疗-B二零二五年中期报告

2025-09-30港股财报落***
AI智能总结
查看更多
微泰医疗-B二零二五年中期报告

2025 2 4 52 62 108 1326 108 9984 24840 H 1617 1366B 15323203–3207 2235 www.microtechmd.com 998 3 2025 245.932024150.8263.1%143.11202474.7291.5%127.04202480.5657.7% 2.29202437.7493.9% 92.812024100.287.4%202466.5%202537.7%18.20202419.707.6%202413.1%20257.4%202563017.16 AiDEX XEquil250% AICGMAI 2025AiDEX XEquil2,500118Equil 2024 2025121.29202438.14218.0%118LinXIDFFIME ATTD 50·20252025BA 1. 2. 3. 20256305216023CE1FDA510(k) — Equil — EquilEquilEquilEquil2017CE2018Equil(2018) Equil AiDEX20212024AiDEX AiDEX XLinXAiDEX XLinX2024220249 PanCares (MPC)2023 IVD 157FDACE136202430 Exactive Pro — Exactive Pro2022CE2023 17—— AiDEX XEquil250% AICGMAI EquilAiDEXPanCares 15,000GMP 202344,000 2025AiDEX XEquil2,500118Equil 2024 2025121.29202438.14218.0%118LinXIDFFIME ATTD 2025630245.932024630150.8263.1% 20252024630 2025630118.89202463070.2569.2% 2025630127.04202463080.5657.7% 20246 30100.287.4%202563092.81(i)AiDEX(ii) 202463019.707.6%202563018.20 202463034.555.7%202563032.57 20252024630 2025630-0.00520246 30-0.01 202463037.7420256302.29 2025630121.01 202563017.162024123116.971.1% 202563030.082.4% 202563010.8%20246307.2% 2025630 2025630 2025630(i)(ii) 202563053.45 2025630 2025630 202563064569.24 20211.420%Equil(AiDEX X) 724400 118 ++2025CGMAiDEX XPanCares ++ AI AI C1C.2.1 C.2.1(i)(ii)(iii) 20245172,390,815.001.0456,000H456,000H2,552,200 2025630() 20256302024630 20256302025630 20211019202111101,875.531,533.492025630 (1) (2)2025630833.6120251231 13.51B(1) 2025630XV352 (1)2025630421,138,000169,235,842H208,205,47443,696,684 (2)L 2025630XVXV78352 2025630XV23XV336 (1)2025630421,138,000169,235,842H208,205,47443,696,684 (3)(i) 11,983,877(ii)9,792,927(iii)3,000,00011,983,877 (4)50%50%11,011,913 (5)15,678,051 (6)(i)3,426,804(ii)6,944,317(iii)2,472,612(iv)1,856,334 (7)12,688,16610,466,0336,343,131H5,232,232H (8)LAV Evergreen (Hong Kong) Co., LimitedLilly Asia Ventures Fund II, L.P.LillyAsia Ventures Fund II, L.P.Lilly Asia Ventures Fund GP, L.P.Lilly Asia Ventures FundGP, L.P.LAV Corporate GP, Ltd.LAV Evergreen (Hong Kong) Co., Limited8,545,840HLAV Star LimitedLAV Fund VI, L.P.LAV Star Opportunities LimitedLAV Fund VI Opportunities, L.P.LAV Fund VI, L.P.LAV Fund VILAV Star LimitedLAV Star Opportunities Limited3,918,700H(i)Lilly Asia Ventures FundII, L.P.Lilly Asia Ventures Fund GP, L.P.LAV Corporate GP, Ltd.LAV Evergreen (Hong Kong) Co., Limited17,091,680(ii)LAV Star LimitedLAV Star OpportunitiesLimitedLAV Evergreen (Hong Kong) Co., Limited12,464,540HLAV Asset Management (Hong Kong) Limited (9)QM32 LimitedQiming Venture Partners V, L.P.96.99%Qiming Venture PartnersV, L.P.Qiming GP V, L.P.Qiming GP V, L.P.Qiming Corporate GP V, Ltd.Qiming Venture Partners V, L.P.Qiming GP V, L.P.Qiming Corporate GP V, Ltd.(i) QM32 Limited11,925,181H(ii) QM32Limited15,190,018 (10)QM153 LimitedQiming Venture Partners VII, L.P.99.09%Qiming GP VII, LLCQiming Venture Partners VII, L.P.Qiming GP VII, LLCQM153 Limited4,458,238 (11)Power SUM LimitedMaster Summer LimitedMaster Summer LimitedCDBI Partners Fund I, L.P.CDBI Partners GP, Ltd.90.52%Master Summer LimitedCDBI Partners Fund I, L.P.CDBI Partners GP, LtdPower SUM Limited6,958,131 (12)OrbiMed Asia Partners V, L.P.OrbiMed Asia GP V, L.P.OrbiMed Asia GP V, L.P.OrbiMed Advisors V LimitedOrbiMedAsia GP V, L.P.OrbiMed Advisors V LimitedOrbiMed Asia Partners V, L.P.19,651,800H (13)Power SUM LimitedMaster Summer LimitedMaster Summer LimitedCD Capital Healthcare FUND V, L.P.CDBI Partners Fund I, L.P.CDBIPartners GP, Ltd37.18%62.82%CD Capital Healthcare FUND V, L.P.CD Capital GP LtdCDBI Partners Fund II, L.P.47.67%CDBI Partners Fund II, L.P.CDBI GP, LtdCD Capital GP LtdCDCapital Healthcare FUND V, L.P.CDBI GP, LtdCDBI Partners Fund I, L.P.CDBI PartnersFund II, L.P.CDBI Partners GP, LtdMaster Summer LimitedPower SUM Limited10,026,231H (14)LAV Evergreen (Hong Kong) Co., LimitedLilly Asia Ventures Fund II, L.P.LillyAsia Ventures Fund II, L.P.Lilly Asia Ventures Fund GP, L.P.Lilly Asia VenturesFund GP, L.P.LAV Corporate GP, LtdLillyAsia Ventures Fund II, L.P.Lilly Asia Ventures Fund GP, L.P.LAV Corporate GP, LtdLAV Evergreen (Hong Kong) Co., Limited8,545,840H (15)LAV Fund VI Opportunities, L.P.LAV Fund VIOpportunities, L.P.LAV GP VI Opportunities, L.P.LAV GP VI Opportunities,L.P.LAV Corporate VI GP Opportunities, Ltd.LAV Fund VI Opportunities, L.P.LAV GP VIOpportunities, L.P.LAV Corporate VI GP Opportunities, Ltd.3,000,000 2025630XV23336 18 2022H 20226222022HHH938,50020251120256302022H7,571,5007,571,500H 1.80%1.80%2022H7,571,500H1.80%H (a)H HHH (i) (ii) (iii)(a)(b)(c) (b)H H (c)H HHH8,510,000HHHHH H 12H (d) H H (e) HH (f)H HHH20226222025630H7 17H 20241227H48938,500(i)135,000(ii)48803,5002024122720256 30 20241227202563036,00036,00036,0006.006.01215,640 20241227202563036,00036,00036,0006.006.01215,640 20241227202563018,00018,00018,0006.006.01107,820 2024122720256309,0009,0009,0006.006.015